Francesco Baratta


Titolo Pubblicato in Anno
Statin liver safety in non-alcoholic fatty liver disease: a systematic review and metanalysis BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 2022
Added fructose in non-alcoholic fatty liver disease and in metabolic sindrome. a narrative review NUTRIENTS 2022
Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Beyond Lipids: The Role in Oxidative Stress and Thrombosis ANTIOXIDANTS 2022
Metabolic syndrome but not fatty liver-associated genetic variants correlates with glomerular renal function decline in patients with non-alcoholic fatty liver disease BIOMEDICINES 2022
Prevention and management of type ii diabetes chronic complications. the role of polyphenols (mini-review) CURRENT MEDICINAL CHEMISTRY 2022
High compliance to mediterranean diet associates with lower platelet activation and liver collagen deposition in patients with nonalcoholic fatty liver disease NUTRIENTS 2022
The sodium–glucose co-transporter-2 (SGLT2) inhibitors reduce platelet activation and thrombus formation by lowering NOX2-related oxidative stress: a pilot study ANTIOXIDANTS 2022
Extra virgin olive oil reduces gut permeability and metabolic endotoxemia in diabetic patients NUTRIENTS 2022
Heterogeneity of non-alcoholic fatty liver disease (NAFLD): implication for cardiovascular risk stratification ATHEROSCLEROSIS 2022
Twelve variants polygenic score for low-density lipoprotein cholesterol distribution in a large cohort of patients with clinically diagnosed familial hypercholesterolemia with or without causative mutations JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE 2022
Sex-related differences in the association between metabolic syndrome and gallstone disease INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2021
Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study INTERNAL AND EMERGENCY MEDICINE 2021
HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD) BIOMEDICINES 2021
Assessment of hepatic fibrosis in MAFLD: A new player in the evaluation of residual cardiovascular risk? DIGESTIVE AND LIVER DISEASE 2021
Statin use and mortality in atrial fibrillation: A systematic review and meta-analysis of 100,287 patients PHARMACOLOGICAL RESEARCH 2021
Proprotein convertase subtilisin kexin type 9 inhibitors reduce platelet activation modulating ox-LDL pathways INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2021
Open issues in the transition from nafld to mafld. the experience of the plinio study INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2021
Is the mediterranean diet the best approach to NAFLD treatment today NUTRIENTS 2021
Nonalcoholic fatty liver disease and the kidney: a review BIOMEDICINES 2021
The challenge of cardiovascular prevention in NAFLD THE LANCET. GASTROENTEROLOGY & HEPATOLOGY 2021

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma